- All Journals
- Al-Qadisiyah University
- Basrah University
- Kirkuk University
- Mosul University
- The Iraqi Borad for Medical Specialization
- University of Anbar
- University of Technology
- Al Mustafa University
- Al-Zahraa University for Women
- Alnoor University
- Kunooz University
- Misan University
- Ninevah University
- Tikrit University
- University of Al-Hamdaniya
- University of Kerbala
Histopathological and Biochemical Assessments of Co-Q10 in Mitigating Submandibular Salivary Gland Toxicity Caused by Trastuzumab and Doxorubicin in Rat Model | ||
| Al-Rafidain Dental Journal | ||
| Article 5, Volume 25, Issue 1, March 2025, Pages 62-79 PDF (1.39 M) | ||
| Document Type: Research Paper | ||
| DOI: 10.33899/rdenj.2023.140012.1206 | ||
| Authors | ||
| Saif-aldeen Husam Alkakaee* 1; Jawnaa Khalid Mamdoh* 2 | ||
| 1Ministry of health - Ninavah health director – Al-Hamdania hospital | ||
| 2Department of Basic dental sciences/College of Dentistry/ University of Mosul/ , Mosul, Iraq | ||
| Abstract | ||
| The aim of this study was to investigate the role of Co-Q10 in reducing the SMG toxicity caused by Trastuzumab and Doxorubicin. The materials and methods were employed to study histopathological measurements by using H&E stains, and serological tests include T-AOC and MDA, in addition to BW. twenty white albino rats were employed, the experiment performed over 20 days, rats divided into 4 groups: G1 in which rats received pure corn oil 1ml/kg orally, over 20 days. G2 in which rats received TRZ+DOX, single dose of 10mg/kg IP at 10th day of the experiment. G3 in which rats received Co-Q10 orally, 10mg/kg daily from day1 to 10th day and TRZ+DOX single dose of 10mg/kg IP of both drugs at 10th day. And G4 in which rats received TRZ+DOX single dose of 10mg/kg IP at 10th day and Co-Q10 orally of 10mg/kg daily from 10th day to the 20th day. In our results; the group in which rats received TRZ+DOX, the histopathological examination revealed many changes comparing with control group, and there was increased serum level of MDA with slight increase in the serum level of T-AOC. In contrast, a vast benefit had obtained from Co-Q10 as protection except for BW which still declined in all groups. The necrosis and degeneration of the submandibular salivary gland cell, and inflammatory cells infiltration, all these findings found to be reduced in groups where rats received Co-Q10 but the benefit was greater in the group that received Co-Q10 before TRZ+DOX, while circulatory disturbances and cell adaptation found to show less benefit from Co-Q10. T-AOC showed higher serum level in groups received Co-Q10, on the other hand, the serum level of MDA was lower in groups administered Co-Q10. Generally, our results concluded for greater benefits from Co-Q10 in reducing SMG toxicity when administered before TRZ+DOX. | ||
| Keywords | ||
| Co-Q10,,; ,،trastuzumab,,; ,،doxorubicin,,; ,،submandibular salivary gland toxicity,,; ,،histopathological changes,,; ,،MDA,,; ,،T-AOC | ||
|
Supplementary Files
|
||
| References | ||
|
1.Netty (Annette) Cracknell and Alan Lamont,Whittlesea and Karen Hodson. Solid tumors. Cate. Clinical pharmacy and therapeutics. 2019.6th edition, Elsevier, Holland; P: 909.
2.Schirrmacher V. From chemotherapy to biological therapy: A review of novel concepts to reduce the side effects of systemic cancer treatment. International journal of oncology. 2019 Feb 1;54(2):407-19.
3. Bikiewicz A, Banach M, von Haehling S, Maciejewski M, Bielecka‐Dabrowa A. Adjuvant breast cancer treatments cardiotoxicity and modern methods of detection and prevention of cardiac complications. ESC Heart Failure. 2021 Aug;8(4):2397-418.
(4) Carneiro-Neto JN, Moura LB, de-Andrade CR. Protocols for management of oral complications of chemotherapy and/or radiotherapy for oral cancer: Systematic review and meta-analysis current. Medicina oral, patologia oral y cirugia bucal. 2017 Jan;22(1):e15.
(5) Bukowski K, Kciuk M, Kontek R. Mechanisms of multidrug resistance in cancer chemotherapy. International journal of molecular sciences. 2020 May 2;21(9):3233.
(6) Fisusi FA, Akala EO. Drug combinations in breast cancer therapy. Pharmaceutical nanotechnology. 2019 Feb 1;7(1):3-23.
(7) Tsimberidou AM, Fountzilas E, Nikanjam M, Kurzrock R. Review of precision cancer medicine: Evolution of the treatment paradigm. Cancer treatment reviews. 2020 Jun 1;86:102019.
(8) Sarosiek T, Morawski P. Trastuzumab and its biosimilars. Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego. 2018 May 1;44(263):253-7.
(9) Keam SJ. Trastuzumab deruxtecan: first approval. Drugs. 2020 Apr;80(5):501-8.
(10) Kitani T, Ong SG, Lam CK, Rhee JW, Zhang JZ, Oikonomopoulos A, Ma N, Tian L, Lee J, Telli ML, Witteles RM. Human-induced pluripotent stem cell model of trastuzumab-induced cardiac dysfunction in patients with breast cancer. Circulation. 2019 May 21;139(21):2451-65.
(11) Shitara K, Iwata H, Takahashi S, Tamura K, Park H, Modi S, Tsurutani J, Kadowaki S, Yamaguchi K, Iwasa S, Saito K. Trastuzumab deruxtecan (DS-8201a) in patients with advanced HER2-positive gastric cancer: a dose-expansion, phase 1 study. The Lancet Oncology. 2019 Jun 1;20(6):827-36.
(12) Whalen K. Lippincott® Illustrated Reviews: Pharmacology. Wolters kluwer india Pvt Ltd; 2018 Oct 25.
(13) Zhu L, Lin M. The synthesis of nano-doxorubicin and its anticancer effect. Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents). 2021 Dec 1;21(18):2466-77.
(14) Kiyuna LA, e Albuquerque RP, Chen CH, Mochly-Rosen D, Ferreira JC. Targeting mitochondrial dysfunction and oxidative stress in heart failure: Challenges and opportunities. Free Radical Biology and Medicine. 2018 Dec 1;129:155-68.
(15) Kawakami K, Matsuo H, Kajitani N, Yamada T, Matsumoto KI. Comparison of survival rates in four inbred mouse strains under different housing conditions: effects of environmental enrichment. Experimental Animals. 2022;71(2):150-60.
(16) Cho DH, Lim IR, Kim JH, Kim MN, Kim YH, Park KH, Park SM, Shim WJ. Protective effects of statin and angiotensin receptor blocker in a rat model of doxorubicin-and trastuzumab-induced cardiomyopathy. Journal of the American Society of Echocardiography. 2020 Oct 1;33(10):1253-63.
(17) Khalel LI, Mammdoh JK, Ahmed AA. The histologic effects of high doses of botulinum toxin a on the rabbit's salivary gland. Iraqi Journal of Veterinary Sciences. 2022 Oct 1;36(4):1111-7.
(18) Zhang Y, Mahmood T, Tang Z, Wu Y, Yuan J. Effects of naturally oxidized corn oil on inflammatory reaction and intestinal health of broilers. Poultry Science. 2022 Jan 1;101(1):101541.
(19) Thimotheo Batista JP, Santos Marzano LA, Menezes Silva RA, de Sá Rodrigues KE, Simõ es e Silva AC. Chemotherapy and Anticancer Drugs Adjustment in Obesity: A Narrative Review. Current Medicinal Chemistry. 2023 Mar 1;30(9):1003-28.
(20) Tao G, Chityala PK. Epidermal growth factor receptor inhibitor-induced diarrhea: clinical incidence, toxicological mechanism, and management. Toxicology Research. 2021 May;10(3):476-86.
(21) Sun W, Wang X, Wang D, Lu L, Lin H, Zhang Z, Jia Y, Nie X, Liu T, Fu W. CD40× HER2 bispecific antibody overcomes the CCL2-induced trastuzumab resistance in HER2-positive gastric cancer. Journal for Immunotherapy of Cancer. 2022;10(7).
(22) Rodak M, Dekempeneer Y, Wojewódzka M, Caveliers V, Covens P, Miller BW, Sevenois MB, Bruchertseifer F, Morgenstern A, Lahoutte T, D'Huyvetter M. Preclinical evaluation of 225Ac-labeled single-domain antibody for the treatment of HER2pos cancer. Molecular Cancer Therapeutics. 2022 Dec 2;21(12):1835-45.
(23) Rodrigues D, Coyle L, Füzi B, Ferreira S, Jo H, Herpers B, Chung SW, Fisher C, Kleinjans JC, Jennen D, de Kok TM. Unravelling mechanisms of doxorubicin-induced toxicity in 3D human intestinal organoids. International Journal of Molecular Sciences. 2022 Jan 24;23(3):1286.
(24) Kim D, Jang G, Hwang J, Wei X, Kim H, Son J, Rhee SJ, Yun KH, Oh SK, Oh CM, Park R. Combined Therapy of Low-Dose Angiotensin Receptor–Neprilysin Inhibitor and Sodium–Glucose Cotransporter-2 Inhibitor Prevents Doxorubicin-Induced Cardiac Dysfunction in Rodent Model with Minimal Adverse Effects. Pharmaceutics. 2022 Nov 28;14(12):2629.
(25) Kang M, Shin JI, Han S, Kim JY, Park J, Kim KI, Kang JH, Lee TS. Therapeutic response monitoring with 89Zr-DFO-pertuzumab in HER2-positive and trastuzumab-resistant breast cancer models. Pharmaceutics. 2022 Jun 24;14(7):1338.
(26) Dou XQ, Wang H, Zhang J, Wang F, Xu GL, Xu CC, Xu HH, Xiang SS, Fu J, Song HF. Aptamer–drug conjugate: Targeted delivery of doxorubicin in a HER3 aptamer-functionalized liposomal delivery system reduces cardiotoxicity. International journal of nanomedicine. 2018;13:763.
(27) Vistoso Monreal A, Polonsky G, Shiboski C, Sankar V, Villa A. Salivary Gland Dysfunction Secondary to Cancer Treatment. Front. Oral complications in cancer patients. 2023 Mar 2;16648714:64.
(28) Schvartsman G, Pinto NA, Bell D, Ferrarotto R. Salivary gland tumors: Molecular characterization and therapeutic advances for metastatic disease. Head & neck. 2019 Jan;41(1):239-47.
(29) Alnuaimi O, Mammdoh J, Al Allaf L. The role of selenium in mitigating the adverse effect of cyclophosphamide on the rat submandibular salivary glands. Egyptian Journal of Veterinary Sciences. 2022 Dec 1;53(4):505-16.
(30) Zhu J, Luo Y, Tong H, Zhong L, Gong Q, Wang Y, Yang M, Song Q. “Drying effect” of fructus aurantii components and the mechanism of action based on network pharmacology and in vitro pharmacodynamic validation. Frontiers in Pharmacology. 2023;14.
(31) Nemeth BT, Varga ZV, Wu WJ, Pacher P. Trastuzumab cardiotoxicity: from clinical trials to experimental studies. British journal of pharmacology. 2017 Nov;174(21):3727-48.
(32) van Herpen C, Vander Poorten V, Skalova A, Terhaard C, Maroldi R, van Engen A, Baujat B, Locati LD, Jensen AD, Smeele L, Hardillo J. Salivary gland cancer: ESMO–European Reference Network on Rare Adult Solid Cancers (EURACAN) Clinical Practice Guideline for diagnosis, treatment and follow-up. ESMO open. 2022 Dec 1;7(6).
(33) Klymiuk I, Bilgilier C, Mahnert A, Prokesch A, Heininger C, Brandl I, Sahbegovic H, Singer C, Fuereder T, Steininger C. Chemotherapy-associated oral microbiome changes in breast cancer patients. Frontiers in Oncology. 2022;12.
(34) Zheng H, Yu Z, Zhou L, Yang X, Liu J. Seasonal abundance and activity of the hard tick Haemaphysalis longicornis (Acari: Ixodidae) in North China. Experimental and applied acarology. 2012 Feb;56:133-41.
(35) Mansy M, Soliman M, Mubarak R, Shamel M. The role of exogenous epidermal growth factor on Ki-67 proliferation marker expression in the submandibular salivary gland of albino rats receiving doxorubicin. F1000Research. 2020;9.
(36) Najafi M, Cheki M, Amini P, Javadi A, Shabeeb D, Musa AE. Evaluating the protective effect of resveratrol, Q10, and alpha-lipoic acid on radiation-induced mice spermatogenesis injury: A histopathological study. International Journal of Reproductive BioMedicine. 2019 Dec;17(12):907.
(37) Ovchinnikov AN, Paoli A, Seleznev VV, Deryugina AV. Royal jelly plus coenzyme Q10 supplementation improves high-intensity interval exercise performance via changes in plasmatic and salivary biomarkers of oxidative stress and muscle damage in swimmers: a randomized, double-blind, placebo-controlled pilot trial. Journal of the International Society of Sports Nutrition. 2022 Dec 31;19(1):239-57.
(38) Dawood GA, A Taqa G, Alnema MM. Histological Effect Of Coq10 On Liver And Buccal Mucosa In Mice. Journal of Applied Veterinary Sciences. 2020 Apr 1;5(2):1-5.
(39) Filipiak KJ, Surma S, Romańczyk M, Okopień B. Heart Failure—Do We Need New Drugs or Have Them Already? A Case of Coenzyme Q10. Journal of Cardiovascular Development and Disease. 2022 May 16;9(5):161.
(40) Casagrande D, Waib PH, Júnior AA. Mechanisms of action and effects of the administration of Coenzyme Q10 on metabolic syndrome. Journal of Nutrition & Intermediary Metabolism. 2018 Sep 1;13:26-32.
(41) Ahmed AA, Mammdoh JK. Expression of Ki67 in submandibular salivary glands of rabbits after BTX injection: Histological and immunohistochemical study. Iraqi Journal of Veterinary Sciences. 2022 Jul 1;36(3):611-20.
(42) Ayers J, Cook J, Koenig RA, Sisson EM, Dixon DL. Recent developments in the role of coenzyme Q10 for coronary heart disease: a systematic review. Current atherosclerosis reports. 2018 Jun;20:1-7.
(43) Awad K, Sayed A, Banach M. Coenzyme Q10 Reduces Infarct Size in Animal Models of Myocardial Ischemia-Reperfusion Injury: A Meta-Analysis and Summary of Underlying Mechanisms. Frontiers in Cardiovascular Medicine. 2022;9.
(44) Dawood Gh A., Taqa Gh A., Alnema M M. Histological Effect of Cytarabine on Liver and Buccal Mucosa in Mice. Al–Rafidain Dent J. 2020 ;20 (1):36-45. DOI: 10.33899/rden.2020.164521
(45) Ebrahim N, Al Saihati HA, Mostafa O, Hassouna A, Abdulsamea S, Abd El Aziz M. El Gebaly E, Abo-Rayah NH, Sabry D, El-Sherbiny M, Madboly AG, Hussien NI. Prophylactic evidence of MSCs-derived exosomes in doxorubicin/trastuzumab-induced cardiotoxicity: beyond mechanistic target of NRG-1/Erb signaling pathway. International Journal of Molecular Sciences. 2022 May 25;23(11):5967.
(46) Ren J, Huang R, Li Y, Chen R, Tian H, Liu C. Radioprotective effects and mechanism of HL-003 on radiation-induced salivary gland damage in mice. Scientific Reports. 2022 May 19;12(1):8419.
(47) Dos Santos VR, Ferreira MK, Bittencourt LO, Mendes PF, Souza-Monteiro D, Balbinot KM, Pinheiro JD, Charone S, Pessan JP, Lima RR. Maternal fluoride exposure exerts different toxicity patterns in parotid and submandibular glands of offspring rats. International Journal of Molecular Sciences. 2022 Jun 29;23(13):7217.
(48) Yi GY, Kim MJ, Kim HI, Park J, Baek SH. Hyperthermia treatment as a promising anti-cancer strategy: Therapeutic targets, perspective mechanisms and synergistic combinations in experimental approaches. Antioxidants. 2022 Mar 24;11(4):625
(49) Gilliam LA, St. Clair DK. Chemotherapy-induced weakness and fatigue in skeletal muscle: the role of oxidative stress. Antioxidants & redox signaling. 2011 Nov 1;15(9):2543-63.
(50) Griñan-Lison C, Blaya-Cánovas JL, López-Tejada A, Ávalos-Moreno M, Navarro-Ocón A, Cara FE, González-González A, Lorente JA, Marchal JA, Granados-Principal S. Antioxidants for the treatment of breast cancer: Are we there yet?. Antioxidants. 2021 Jan 31;10(2):205.
(51) Gulcin İ. Antioxidants and antioxidant methods: An updated overview. Archives of toxicology. 2020 Mar;94(3):651-715.
(52) Christiansen LB, Morsing MK, Reimann MJ, Martinussen T, Birlie Z, Schou-Pedersen AM, Lykkesfeldt J, Olsen LH. Pharmacokinetics of repeated oral dosing with coenzyme Q10 in cavalier king charles spaniels with myxomatous mitral valve disease. Antioxidants. 2020 Sep 4;9(9):827. | ||
|
Statistics Article View: 1,642 PDF Download: 233 |
||
